ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,509.01
0.62%
US Tech 100
19,483.60
0.02%
Dow Jones
39,331.85
0.00%
Brent Oil
86.275
-0.20%
Bitcoin
60,129.86
-3.06%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Harrow Inc (HROW)

  7. Harrow Inc (HROW) News

HROW

Harrow (HROW)

Harrow Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HROW
DateTimeSourceHeadlineSymbolCompany
06/20/20247:00AMBusiness WireHarrow Provides TRIESENCE® Relaunch UpdateNASDAQ:HROWHarrow Inc
06/06/20248:00AMBusiness WireMelt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract SurgeryNASDAQ:HROWHarrow Inc
06/05/20247:00AMBusiness WireHarrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension StudyNASDAQ:HROWHarrow Inc
05/15/20247:00AMBusiness WireHarrow to Present at Two Investor Conferences in MayNASDAQ:HROWHarrow Inc
05/13/20244:01PMBusiness WireHarrow Announces First Quarter 2024 Financial ResultsNASDAQ:HROWHarrow Inc
05/13/20247:00AMBusiness WireHarrow Names Greg DiPasquale as Senior Vice President, Head of CommercialNASDAQ:HROWHarrow Inc
04/25/20247:00AMBusiness WireHarrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024NASDAQ:HROWHarrow Inc
04/02/20248:16AMBusiness WireMelt Pharmaceuticals Closes $24 Million Series B Preferred Stock FinancingNASDAQ:HROWHarrow Inc
03/20/20247:15AMIH Market NewsJPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest NewsNASDAQ:HROWHarrow Inc
03/19/20245:45PMBusiness WireHarrow Announces Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:HROWHarrow Inc
03/19/20247:27AMIH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:HROWHarrow Inc
03/06/20246:06AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
03/05/20247:00AMBusiness WireHarrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024NASDAQ:HROWHarrow Inc
02/21/20247:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
02/21/20247:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
02/15/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
02/15/20244:01PMBusiness WireHarrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical ProductsNASDAQ:HROWHarrow Inc
02/09/20244:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HROWHarrow Inc
02/08/20247:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
01/29/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
01/29/20243:26PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:HROWHarrow Inc
01/29/20247:00AMBusiness WireHarrow Announces New Appointments to its Board of DirectorsNASDAQ:HROWHarrow Inc
01/11/20247:00AMBusiness WireHarrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye DiseaseNASDAQ:HROWHarrow Inc
01/09/202410:16AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:HROWHarrow Inc
01/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HROWHarrow Inc
01/03/20247:15AMBusiness WireMelt Pharmaceuticals Provides Corporate UpdateNASDAQ:HROWHarrow Inc
01/03/20247:00AMBusiness WireHarrow Partners with Leading Healthcare Market Access Technology PlatformsNASDAQ:HROWHarrow Inc
11/29/20237:00AMBusiness WireHarrow Completes Transfer of the TRIESENCE® New Drug ApplicationNASDAQ:HROWHarrow Inc
11/20/20237:00AMBusiness WireHarrow to Present at Two Investor Conferences in NovemberNASDAQ:HROWHarrow Inc
11/16/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HROWHarrow Inc
 Showing the most relevant articles for your search:NASDAQ:HROW

Your Recent History

NASDAQ
TSLA
Tesla
USOTC
NNAX
New Momentum (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
CNNA
Cann American (CE)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
AXXA
Exxe (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
PHIL
PHI (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
GGSM
Gold and GemStone Mining (PK)
USOTC
SMCE
SMC Entertainment (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved